Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG Intron vs Intron A in Multiple Myeloma
NCT00323505Phase 2Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Mar 2001
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2b in multiple myeloma (MM), sponsored by Royal Marsden NHS Foundation Trust. Started Mar 2001; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00323505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323505.